Epilepsy-intellectual disability in females
(Redirected from Juberg-Hellman syndrome)
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
Epilepsy-intellectual disability in females | |
---|---|
![]() | |
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Seizures, intellectual disability, developmental delay |
Complications | N/A |
Onset | Childhood |
Duration | Lifelong |
Types | N/A |
Causes | Genetic mutations |
Risks | Family history |
Diagnosis | Genetic testing, EEG, MRI |
Differential diagnosis | Rett syndrome, Lennox-Gastaut syndrome |
Prevention | N/A |
Treatment | Antiepileptic drugs, supportive care |
Medication | N/A |
Prognosis | Variable |
Frequency | Rare |
Deaths | N/A |
Epilepsy-intellectual disability in females is a rare genetic disorder characterized by the co-occurrence of epilepsy and intellectual disability primarily affecting females. This condition is part of a broader category of disorders known as X-linked intellectual disability (XLID) due to its pattern of inheritance. The disorder highlights the complex interplay between genetics, gender, and neurological development.
Causes
Epilepsy-intellectual disability in females is often caused by mutations in genes located on the X chromosome. One of the most studied genes associated with this condition is the PCDH19 gene, which encodes the protocadherin 19 protein. Mutations in this gene disrupt cell signaling pathways that are crucial for brain development and function, leading to the symptoms observed in affected individuals. Because females have two X chromosomes, a mutation in one of the copies of the gene on one X chromosome can lead to the disorder, while males, having only one X chromosome, are less likely to be affected.
Symptoms
The primary symptoms of this disorder include the onset of seizures in early childhood and varying degrees of intellectual disability. The type and severity of seizures can vary widely among affected individuals. Other possible symptoms may include developmental delays, behavioral problems, and in some cases, features of autism spectrum disorder (ASD).
Diagnosis
Diagnosis of epilepsy-intellectual disability in females typically involves a combination of clinical evaluation, family history, and genetic testing. Genetic testing can confirm the presence of mutations in the PCDH19 gene or other genes associated with the condition. Neurological assessments and imaging studies, such as MRI scans, may also be used to rule out other causes of seizures and intellectual disability.
Treatment
Treatment for epilepsy-intellectual disability in females is symptomatic and may include the use of antiepileptic drugs (AEDs) to manage seizures. The choice of AEDs depends on the type of seizures and their frequency. In addition to medication, individuals may benefit from educational support, behavioral therapy, and other interventions aimed at improving cognitive function and quality of life.
Prognosis
The prognosis for individuals with epilepsy-intellectual disability in females varies depending on the severity of the symptoms and the effectiveness of treatment. While some individuals may experience improvement in seizure control and cognitive abilities with appropriate treatment, others may continue to face challenges related to seizures, intellectual disability, and behavioral issues.
Epidemiology
Epilepsy-intellectual disability in females is considered a rare disorder, though the exact prevalence is unknown. The condition is underdiagnosed, partly due to the variability in symptoms and the complexity of genetic testing.
Research Directions
Research on epilepsy-intellectual disability in females is focused on understanding the genetic mechanisms underlying the disorder and developing more effective treatments. Studies on animal models and cell cultures are exploring the role of the PCDH19 gene and other related genes in brain development. Clinical trials are investigating new therapeutic approaches, including targeted therapies that address the specific genetic mutations involved in the disorder.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD